Mohammad Amjad Kamal

InstitutionNovel Global Community Educational Foundation
AddressAustralia
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 26 Covid-19 publications, with a maximum of 11 publications in January 2021
    All Publications
    Bar chart showing 298 publications over 18 distinct years, with a maximum of 76 publications in 2014
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Sharma S, Batra S, Gupta S, Sharma VK, Rahman MH, Kamal MA. Persons with Co-Existing Neurological Disorders: Risk Analysis, Considerations and Management in COVID-19 Pandemic. CNS Neurol Disord Drug Targets. 2022; 21(3):228-234. PMID: 33687889.
      Citations: 3     Fields:    
    2. Singh IK, Kumari P, Mittal P, Kumar A, Singal B, Hasan GM, Aggarwal R, Kamal MA, Singh A, Hassan MI. Emerging Therapeutic Approaches to COVID-19. Curr Pharm Des. 2021 10 05; 27(31):3370-3388. PMID: 33550964.
      Citations:    Fields:    Translation:Humans
    3. Singh R, Singh PK, Kumar R, Kabir MT, Kamal MA, Rauf A, Albadrani GM, Sayed AA, Mousa SA, Abdel-Daim MM, Uddin MS. Multi-Omics Approach in the Identification of Potential Therapeutic Biomolecule for COVID-19. Front Pharmacol. 2021; 12:652335. PMID: 34054532.
      Citations: 2     
    4. Islam MA, Kundu S, Alam SS, Hossan T, Kamal MA, Hassan R. Prevalence and characteristics of fever in adult and paediatric patients with coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis of 17515 patients. PLoS One. 2021; 16(4):e0249788. PMID: 33822812.
      Citations: 8     Fields:    Translation:HumansPHPublic Health
    5. Bharadwaj S, El-Kafrawy SA, Alandijany TA, Bajrai LH, Shah AA, Dubey A, Sahoo AK, Yadava U, Kamal MA, Azhar EI, Kang SG, Dwivedi VD. Structure-Based Identification of Natural Products as SARS-CoV-2 Mpro Antagonist from Echinacea angustifolia Using Computational Approaches. Viruses. 2021 02 15; 13(2). PMID: 33672054.
      Citations: 3     Fields:    Translation:AnimalsCells
    6. El-Kafrawy SA, El-Daly MM, Hassan AM, Kaki RM, Abuzenadah AM, Kamal MA, Azhar EI. A Direct Method for RT-PCR Detection of SARS-CoV-2 in Clinical Samples. Healthcare (Basel). 2021 Jan 04; 9(1). PMID: 33406585.
      Citations: 2     
    7. Kamal MA, Khan MA. Viral Diseases and Natural Products: Prospects in COVID-19 Treatment (Part II). Curr Pharm Des. 2021; 27(9):1121-1122. PMID: 34009111.
      Citations:    Fields:    Translation:Humans
    8. Anwar F, Altayb HN, Al-Abbasi FA, Kumar V, Kamal MA, Kamal MA. The Computational Intervention of Macrolide Antibiotics in the Treatment of COVID-19. Curr Pharm Des. 2021; 27(9):1202-1210. PMID: 33550966.
      Citations:    Fields:    Translation:HumansCells
    9. Azhar A, Hassan N, Singh M, Al-Hosaini K, Kamal MA. Synopsis of Pharmotechnological Approaches in Diagnostic and Management Strategies for Fighting Against COVID-19. Curr Pharm Des. 2021; 27(39):4086-4099. PMID: 34269664.
      Citations:    Fields:    Translation:HumansPHPublic Health
    10. Alshammary F, Siddiqui AA, Amin J, Ilyas M, Rathore HA, Hassan I, Alam MK, Kamal MA. Prevention Knowledge and Its Practice Towards COVID-19 Among General Population of Saudi Arabia: A Gender-based Perspective. Curr Pharm Des. 2021; 27(13):1642-1648. PMID: 32811408.
      Citations: 7     Fields:    Translation:Humans
    11. Anwar F, Naqvi S, Al-Abbasi FA, Neelofar N, Kumar V, Sahoo A, Kamal MA. Targeting COVID-19 in Parkinson's Patients: Drugs Repurposed. Curr Med Chem. 2021; 28(12):2392-2408. PMID: 32881656.
      Citations: 3     Fields:    Translation:HumansPHPublic Health
    12. Bibi S, Sarfraz A, Mustafa G, Ahmad Z, Zeb MA, Wang YB, Khan T, Khan MS, Kamal MA, Kamal MA, Yu H. Impact of Traditional Plants and their Secondary Metabolites in the Discovery of COVID-19 Treatment. Curr Pharm Des. 2021; 27(9):1123-1143. PMID: 33213320.
      Citations:    Fields:    Translation:Humans
    13. Bhat MA, Rahman S, Rather IA, Banday MI, Syed S, Koser H, Kamal MA, Minakshi R, Jan AT. Coronavirus Disease -2019 (COVID-19) in 2020: A Perspective Study of a Global Pandemic. Curr Pharm Des. 2021; 27(32):3435-3443. PMID: 33213324.
      Citations: 2     Fields:    Translation:HumansAnimalsPHPublic Health
    14. Fatima U, Rizvi SSA, Raina N, Fatima S, Rahman S, Kamal MA, Hassan MI. Therapeutic Management of COVID-19 Patients: Clinical Manifestation and Limitations. Curr Pharm Des. 2021; 27(41):4223-4231. PMID: 33238869.
      Citations: 2     Fields:    Translation:HumansPHPublic Health
    15. Satyam R, Bhardwaj T, Goel S, Jha NK, Jha SK, Nand P, Ruokolainen J, Kamal MA, Kesari KK. miRNAs in SARS-CoV 2: A Spoke in the Wheel of Pathogenesis. Curr Pharm Des. 2021; 27(13):1628-1641. PMID: 33023438.
      Citations: 7     Fields:    Translation:Humans
    16. Sohrab SS, Suhail M, Kamal MA, Azhar EI. Natural Products Homoharringtonine and Emetine Alkaloids as SARS-CoV-2 Treatment Options. Curr Pharm Des. 2021; 27(32):3444-3453. PMID: 33302852.
      Citations:    Fields:    Translation:HumansAnimals
    17. Abu-Izneid T, AlHajri N, Ibrahim AM, Javed MN, Salem KM, Pottoo FH, Kamal MA. Micro-RNAs in the regulation of immune response against SARS CoV-2 and other viral infections. J Adv Res. 2021 05; 30:133-145. PMID: 33282419.
      Citations: 4     Translation:HumansCells
    18. Batool A, Bibi N, Amin F, Kamal MA. Drug designing against NSP15 of SARS-COV2 via high throughput computational screening and structural dynamics approach. Eur J Pharmacol. 2021 Feb 05; 892:173779. PMID: 33275961.
      Citations: 2     Fields:    Translation:Cells
    19. Islam MA, Alam SS, Kundu S, Hossan T, Kamal MA, Cavestro C. Prevalence of Headache in Patients With Coronavirus Disease 2019 (COVID-19): A Systematic Review and Meta-Analysis of 14,275 Patients. Front Neurol. 2020; 11:562634. PMID: 33329305.
      Citations: 16     
    20. Bharadwaj S, Azhar EI, Kamal MA, Bajrai LH, Dubey A, Jha K, Yadava U, Kang SG, Dwivedi VD. SARS-CoV-2 Mpro inhibitors: identification of anti-SARS-CoV-2 Mpro compounds from FDA approved drugs. J Biomol Struct Dyn. 2020 Nov 05; 1-16. PMID: 33150855.
      Citations: 5     Fields:    
    21. Satyam R, Jha NK, Kar R, Jha SK, Sharma A, Kumar D, Nand P, Ruokolainen J, Kesari KK, Kamal MA. Deciphering the SSR incidences across viral members of Coronaviridae family. Chem Biol Interact. 2020 Nov 01; 331:109226. PMID: 32971122.
      Citations: 3     Fields:    Translation:HumansCells
    22. Bibi N, Gul S, Ali J, Kamal MA. Viroinformatics approach to explore the inhibitory mechanism of existing drugs repurposed to fight against COVID-19. Eur J Pharmacol. 2020 Oct 15; 885:173496. PMID: 32841640.
      Citations: 4     Fields:    Translation:HumansCellsPHPublic Health
    23. Anwar F, Altayb HN, Al-Abbasi FA, Al-Malki AL, Kamal MA, Kumar V. Antiviral effects of probiotic metabolites on COVID-19. J Biomol Struct Dyn. 2021 07; 39(11):4175-4184. PMID: 32475223.
      Citations: 13     Fields:    Translation:HumansCells
    24. Rahman MH, Akter R, Behl T, Chowdhury MAR, Mohammed M, Bulbul IJ, Elshenawy SE, Kamal MA, Kamal MA. COVID-19 Outbreak and Emerging Management through Pharmaceutical Therapeutic Strategy. Curr Pharm Des. 2020; 26(41):5224-5240. PMID: 32660401.
      Citations: 6     Fields:    Translation:HumansPHPublic Health
    25. Sohrab SS, Sohrab SS, Suhail M, Kamal MA, Kamal MA, Ahmad F, Azhar EI, Azhar EI. The Emergence of Human Pathogenic Coronaviruses: Lectins as Antivirals for SARS-CoV-2. Curr Pharm Des. 2020; 26(41):5286-5292. PMID: 32954998.
      Citations: 3     Fields:    Translation:HumansCells
    26. Kamal MA, Khan MA. Viral Diseases and Natural Products: Prospects in COVID-19 Treatment (Part-I). Curr Pharm Des. 2020; 26(41):5221-5223. PMID: 33327907.
      Citations:    Fields:    Translation:Humans
    27. Sohrab SS, El-Kafrawy SA, Mirza Z, Kamal MA, Azhar EI. Design and Delivery of Therapeutic siRNAs: Application to MERS-Coronavirus. Curr Pharm Des. 2018; 24(1):62-77. PMID: 29119921.
      Citations: 14     Fields:    Translation:HumansCells
    Kamal's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (405)
    Explore
    _
    Co-Authors (134)
    Explore
    _
    Similar People (60)
    Explore
    _